+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Erectile Dysfunction (ED) Drugs Market 2026-2030

  • PDF Icon

    Report

  • 296 Pages
  • February 2026
  • Region: Global
  • TechNavio
  • ID: 5558009
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global erectile dysfunction (ed) drugs market is forecasted to grow by USD 1.75 billion during 2025-2030, accelerating at a CAGR of 7.1% during the forecast period. The report on the global erectile dysfunction (ed) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for erectile dysfunction drugs, rising awareness of erectile dysfunction drugs, high prevalence of conditions resulting in erectile dysfunction.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The global erectile dysfunction (ed) drugs market is segmented as below:

By Distribution Channel

  • Hospital pharmacy
  • Retail pharmacy
  • Online pharmacy

By Product

  • Oral drugs
  • Topical drugs
  • Others

By Type

  • Sildenafil
  • Tadalafil
  • Vardenafil
  • Avanafil
  • Others

By Region

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • The Netherlands
  • Russia
  • Asia
  • Rest of World (RoW)
This study identifies the presence of novel drug formulations in late stages of development as one of the prime reasons driving the global erectile dysfunction (ed) drugs market growth during the next few years. Also, expanding research for development of novel therapies and increasing otc abuse of drugs will lead to sizable demand in the market.

The report on the global erectile dysfunction (ed) drugs market covers the following areas:

  • Global erectile dysfunction (ed) drugs market sizing
  • Global erectile dysfunction (ed) drugs market forecast
  • Global erectile dysfunction (ed) drugs market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global erectile dysfunction (ed) drugs market vendors that include A. Menarini Industrie Farma, Aseric Pharma, Aurobindo Pharma Ltd., Bayer AG, Cipla Inc., Dong A Socio Holdings Co. Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., Lupin Ltd., Nippon Shinyaku Co. Ltd., Pfizer Inc., Sandoz Group AG, Sanofi SA, SK Chemicals Co. Ltd., Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., Viatris Inc., VIVUS LLC. Also, the global erectile dysfunction (ed) drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
  • Chart on Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
  • Chart on Overview on factors of disruption
2.4 Impact of drivers and challenges
  • Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
  • Chart on Parent Market
  • Data Table on - Parent Market
3.2 Market characteristics
  • Chart on Market characteristics analysis
3.3 Value chain analysis
  • Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
  • Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
  • Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
  • Chart on Global - Market size and forecast 2025-2030 ($ million)
  • Data Table on Global - Market size and forecast 2025-2030 ($ million)
  • Chart on Global Market: Year-over-year growth 2025-2030 (%)
  • Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Erectile Dysfunction (ED) Drugs Market 2020 - 2024
  • Historic Market Size - Data Table on Global Erectile Dysfunction (ED) Drugs Market 2020 - 2024 ($ million)
5.2 Distribution Channel segment analysis 2020 - 2024
  • Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
5.3 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
5.4 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ million)
5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 The Impact of AI on the Global Erectile Dysfunction (ED) Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
  • Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Distribution Channel
8.1 Market segments
  • Chart on Distribution Channel - Market share 2025-2030 (%)
  • Data Table on Distribution Channel - Market share 2025-2030 (%)
8.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
8.3 Hospital pharmacy - Market size and forecast 2025-2030
  • Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
  • Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
  • Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
  • Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
8.4 Retail pharmacy - Market size and forecast 2025-2030
  • Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
  • Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
  • Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
  • Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
8.5 Online pharmacy - Market size and forecast 2025-2030
  • Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
  • Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
  • Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
  • Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
8.6 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ million)
  • Data Table on Market opportunity by Distribution Channel ($ million)
9 Market Segmentation by Product
9.1 Market segments
  • Chart on Product - Market share 2025-2030 (%)
  • Data Table on Product - Market share 2025-2030 (%)
9.2 Comparison by Product
  • Chart on Comparison by Product
  • Data Table on Comparison by Product
9.3 Oral drugs - Market size and forecast 2025-2030
  • Chart on Oral drugs - Market size and forecast 2025-2030 ($ million)
  • Data Table on Oral drugs - Market size and forecast 2025-2030 ($ million)
  • Chart on Oral drugs - Year-over-year growth 2025-2030 (%)
  • Data Table on Oral drugs - Year-over-year growth 2025-2030 (%)
9.4 Topical drugs - Market size and forecast 2025-2030
  • Chart on Topical drugs - Market size and forecast 2025-2030 ($ million)
  • Data Table on Topical drugs - Market size and forecast 2025-2030 ($ million)
  • Chart on Topical drugs - Year-over-year growth 2025-2030 (%)
  • Data Table on Topical drugs - Year-over-year growth 2025-2030 (%)
9.5 Others - Market size and forecast 2025-2030
  • Chart on Others - Market size and forecast 2025-2030 ($ million)
  • Data Table on Others - Market size and forecast 2025-2030 ($ million)
  • Chart on Others - Year-over-year growth 2025-2030 (%)
  • Data Table on Others - Year-over-year growth 2025-2030 (%)
9.6 Market opportunity by Product
  • Market opportunity by Product ($ million)
  • Data Table on Market opportunity by Product ($ million)
10 Market Segmentation by Type
10.1 Market segments
  • Chart on Type - Market share 2025-2030 (%)
  • Data Table on Type - Market share 2025-2030 (%)
10.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
10.3 Sildenafil - Market size and forecast 2025-2030
  • Chart on Sildenafil - Market size and forecast 2025-2030 ($ million)
  • Data Table on Sildenafil - Market size and forecast 2025-2030 ($ million)
  • Chart on Sildenafil - Year-over-year growth 2025-2030 (%)
  • Data Table on Sildenafil - Year-over-year growth 2025-2030 (%)
10.4 Tadalafil - Market size and forecast 2025-2030
  • Chart on Tadalafil - Market size and forecast 2025-2030 ($ million)
  • Data Table on Tadalafil - Market size and forecast 2025-2030 ($ million)
  • Chart on Tadalafil - Year-over-year growth 2025-2030 (%)
  • Data Table on Tadalafil - Year-over-year growth 2025-2030 (%)
10.5 Vardenafil - Market size and forecast 2025-2030
  • Chart on Vardenafil - Market size and forecast 2025-2030 ($ million)
  • Data Table on Vardenafil - Market size and forecast 2025-2030 ($ million)
  • Chart on Vardenafil - Year-over-year growth 2025-2030 (%)
  • Data Table on Vardenafil - Year-over-year growth 2025-2030 (%)
10.6 Avanafil - Market size and forecast 2025-2030
  • Chart on Avanafil - Market size and forecast 2025-2030 ($ million)
  • Data Table on Avanafil - Market size and forecast 2025-2030 ($ million)
  • Chart on Avanafil - Year-over-year growth 2025-2030 (%)
  • Data Table on Avanafil - Year-over-year growth 2025-2030 (%)
10.7 Others - Market size and forecast 2025-2030
  • Chart on Others - Market size and forecast 2025-2030 ($ million)
  • Data Table on Others - Market size and forecast 2025-2030 ($ million)
  • Chart on Others - Year-over-year growth 2025-2030 (%)
  • Data Table on Others - Year-over-year growth 2025-2030 (%)
10.8 Market opportunity by Type
  • Market opportunity by Type ($ million)
  • Data Table on Market opportunity by Type ($ million)
11 Customer Landscape
11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
  • Chart on Market share by geography 2025-2030 (%)
  • Data Table on Market share by geography 2025-2030 (%)
12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
12.3 North America - Market size and forecast 2025-2030
  • Chart on North America - Market size and forecast 2025-2030 ($ million)
  • Data Table on North America - Market size and forecast 2025-2030 ($ million)
  • Chart on North America - Year-over-year growth 2025-2030 (%)
  • Data Table on North America - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - North America
  • Data Table on Regional Comparison - North America
12.3.1 US - Market size and forecast 2025-2030
  • Chart on US - Market size and forecast 2025-2030 ($ million)
  • Data Table on US - Market size and forecast 2025-2030 ($ million)
  • Chart on US - Year-over-year growth 2025-2030 (%)
  • Data Table on US - Year-over-year growth 2025-2030 (%)
12.3.2 Canada - Market size and forecast 2025-2030
  • Chart on Canada - Market size and forecast 2025-2030 ($ million)
  • Data Table on Canada - Market size and forecast 2025-2030 ($ million)
  • Chart on Canada - Year-over-year growth 2025-2030 (%)
  • Data Table on Canada - Year-over-year growth 2025-2030 (%)
12.3.3 Mexico - Market size and forecast 2025-2030
  • Chart on Mexico - Market size and forecast 2025-2030 ($ million)
  • Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
  • Chart on Mexico - Year-over-year growth 2025-2030 (%)
  • Data Table on Mexico - Year-over-year growth 2025-2030 (%)
12.4 Europe - Market size and forecast 2025-2030
  • Chart on Europe - Market size and forecast 2025-2030 ($ million)
  • Data Table on Europe - Market size and forecast 2025-2030 ($ million)
  • Chart on Europe - Year-over-year growth 2025-2030 (%)
  • Data Table on Europe - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Europe
  • Data Table on Regional Comparison - Europe
12.4.1 UK - Market size and forecast 2025-2030
  • Chart on UK - Market size and forecast 2025-2030 ($ million)
  • Data Table on UK - Market size and forecast 2025-2030 ($ million)
  • Chart on UK - Year-over-year growth 2025-2030 (%)
  • Data Table on UK - Year-over-year growth 2025-2030 (%)
12.4.2 Germany - Market size and forecast 2025-2030
  • Chart on Germany - Market size and forecast 2025-2030 ($ million)
  • Data Table on Germany - Market size and forecast 2025-2030 ($ million)
  • Chart on Germany - Year-over-year growth 2025-2030 (%)
  • Data Table on Germany - Year-over-year growth 2025-2030 (%)
12.4.3 France - Market size and forecast 2025-2030
  • Chart on France - Market size and forecast 2025-2030 ($ million)
  • Data Table on France - Market size and forecast 2025-2030 ($ million)
  • Chart on France - Year-over-year growth 2025-2030 (%)
  • Data Table on France - Year-over-year growth 2025-2030 (%)
12.4.4 Italy - Market size and forecast 2025-2030
  • Chart on Italy - Market size and forecast 2025-2030 ($ million)
  • Data Table on Italy - Market size and forecast 2025-2030 ($ million)
  • Chart on Italy - Year-over-year growth 2025-2030 (%)
  • Data Table on Italy - Year-over-year growth 2025-2030 (%)
12.4.5 Spain - Market size and forecast 2025-2030
  • Chart on Spain - Market size and forecast 2025-2030 ($ million)
  • Data Table on Spain - Market size and forecast 2025-2030 ($ million)
  • Chart on Spain - Year-over-year growth 2025-2030 (%)
  • Data Table on Spain - Year-over-year growth 2025-2030 (%)
12.4.6 The Netherlands - Market size and forecast 2025-2030
  • Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
  • Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
  • Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
  • Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
12.4.7 Russia - Market size and forecast 2025-2030
  • Chart on Russia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Russia - Market size and forecast 2025-2030 ($ million)
  • Chart on Russia - Year-over-year growth 2025-2030 (%)
  • Data Table on Russia - Year-over-year growth 2025-2030 (%)
12.5 Asia - Market size and forecast 2025-2030
  • Chart on Asia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Asia - Market size and forecast 2025-2030 ($ million)
  • Chart on Asia - Year-over-year growth 2025-2030 (%)
  • Data Table on Asia - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Asia
  • Data Table on Regional Comparison - Asia
12.5.1 China - Market size and forecast 2025-2030
  • Chart on China - Market size and forecast 2025-2030 ($ million)
  • Data Table on China - Market size and forecast 2025-2030 ($ million)
  • Chart on China - Year-over-year growth 2025-2030 (%)
  • Data Table on China - Year-over-year growth 2025-2030 (%)
12.5.2 Japan - Market size and forecast 2025-2030
  • Chart on Japan - Market size and forecast 2025-2030 ($ million)
  • Data Table on Japan - Market size and forecast 2025-2030 ($ million)
  • Chart on Japan - Year-over-year growth 2025-2030 (%)
  • Data Table on Japan - Year-over-year growth 2025-2030 (%)
12.5.3 India - Market size and forecast 2025-2030
  • Chart on India - Market size and forecast 2025-2030 ($ million)
  • Data Table on India - Market size and forecast 2025-2030 ($ million)
  • Chart on India - Year-over-year growth 2025-2030 (%)
  • Data Table on India - Year-over-year growth 2025-2030 (%)
12.5.4 South Korea - Market size and forecast 2025-2030
  • Chart on South Korea - Market size and forecast 2025-2030 ($ million)
  • Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
  • Chart on South Korea - Year-over-year growth 2025-2030 (%)
  • Data Table on South Korea - Year-over-year growth 2025-2030 (%)
12.5.5 Indonesia - Market size and forecast 2025-2030
  • Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
  • Chart on Indonesia - Year-over-year growth 2025-2030 (%)
  • Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
12.5.6 Thailand - Market size and forecast 2025-2030
  • Chart on Thailand - Market size and forecast 2025-2030 ($ million)
  • Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
  • Chart on Thailand - Year-over-year growth 2025-2030 (%)
  • Data Table on Thailand - Year-over-year growth 2025-2030 (%)
12.5.7 Singapore - Market size and forecast 2025-2030
  • Chart on Singapore - Market size and forecast 2025-2030 ($ million)
  • Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
  • Chart on Singapore - Year-over-year growth 2025-2030 (%)
  • Data Table on Singapore - Year-over-year growth 2025-2030 (%)
12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
  • Chart on Regional Comparison - Rest of World (ROW)
  • Data Table on Regional Comparison - Rest of World (ROW)
12.6.1 Australia - Market size and forecast 2025-2030
  • Chart on Australia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Australia - Market size and forecast 2025-2030 ($ million)
  • Chart on Australia - Year-over-year growth 2025-2030 (%)
  • Data Table on Australia - Year-over-year growth 2025-2030 (%)
12.6.2 Brazil - Market size and forecast 2025-2030
  • Chart on Brazil - Market size and forecast 2025-2030 ($ million)
  • Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
  • Chart on Brazil - Year-over-year growth 2025-2030 (%)
  • Data Table on Brazil - Year-over-year growth 2025-2030 (%)
12.6.3 UAE - Market size and forecast 2025-2030
  • Chart on UAE - Market size and forecast 2025-2030 ($ million)
  • Data Table on UAE - Market size and forecast 2025-2030 ($ million)
  • Chart on UAE - Year-over-year growth 2025-2030 (%)
  • Data Table on UAE - Year-over-year growth 2025-2030 (%)
12.6.4 South Africa - Market size and forecast 2025-2030
  • Chart on South Africa - Market size and forecast 2025-2030 ($ million)
  • Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
  • Chart on South Africa - Year-over-year growth 2025-2030 (%)
  • Data Table on South Africa - Year-over-year growth 2025-2030 (%)
12.6.5 Saudi Arabia - Market size and forecast 2025-2030
  • Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  • Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
  • Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
  • Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
12.6.6 Turkey - Market size and forecast 2025-2030
  • Chart on Turkey - Market size and forecast 2025-2030 ($ million)
  • Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
  • Chart on Turkey - Year-over-year growth 2025-2030 (%)
  • Data Table on Turkey - Year-over-year growth 2025-2030 (%)
12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
  • Rising demand for erectile dysfunction drugs
  • Rising awareness of erectile dysfunction drugs
  • High prevalence of conditions resulting in erectile dysfunction
13.2 Market challenges
  • Availability of generics drugs
  • Side-effects of available drugs
  • Poor reimbursement scenario
13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
  • Presence of novel drug formulations in late stages of development
  • Expanding research for development of novel therapies
  • Increasing OTC abuse of drugs
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
  • Overview on factors of disruption
14.4 Industry risks
  • Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
  • Companies covered
15.2 Company ranking index
  • Company ranking index
15.3 Market positioning of companies
  • Matrix on companies position and classification
15.4 A. Menarini Industrie Farma
  • A. Menarini Industrie Farma - Overview
  • A. Menarini Industrie Farma - Product / Service
  • A. Menarini Industrie Farma - Key offerings
  • SWOT
15.5 Aseric Pharma
  • Aseric Pharma - Overview
  • Aseric Pharma - Product / Service
  • Aseric Pharma - Key offerings
  • SWOT
15.6 Aurobindo Pharma Ltd.
  • Aurobindo Pharma Ltd. - Overview
  • Aurobindo Pharma Ltd. - Product / Service
  • Aurobindo Pharma Ltd. - Key offerings
  • SWOT
15.7 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
15.8 Cipla Inc.
  • Cipla Inc. - Overview
  • Cipla Inc. - Business segments
  • Cipla Inc. - Key news
  • Cipla Inc. - Key offerings
  • Cipla Inc. - Segment focus
  • SWOT
15.9 Dong A Socio Holdings Co. Ltd.
  • Dong A Socio Holdings Co. Ltd. - Overview
  • Dong A Socio Holdings Co. Ltd. - Product / Service
  • Dong A Socio Holdings Co. Ltd. - Key offerings
  • SWOT
15.10 Dr. Reddys Laboratories Ltd.
  • Dr. Reddys Laboratories Ltd. - Overview
  • Dr. Reddys Laboratories Ltd. - Business segments
  • Dr. Reddys Laboratories Ltd. - Key news
  • Dr. Reddys Laboratories Ltd. - Key offerings
  • Dr. Reddys Laboratories Ltd. - Segment focus
  • SWOT
15.11 Eli Lilly and Co.
  • Eli Lilly and Co. - Overview
  • Eli Lilly and Co. - Product / Service
  • Eli Lilly and Co. - Key offerings
  • SWOT
15.12 Lupin Ltd.
  • Lupin Ltd. - Overview
  • Lupin Ltd. - Business segments
  • Lupin Ltd. - Key news
  • Lupin Ltd. - Key offerings
  • Lupin Ltd. - Segment focus
  • SWOT
15.13 Nippon Shinyaku Co. Ltd.
  • Nippon Shinyaku Co. Ltd. - Overview
  • Nippon Shinyaku Co. Ltd. - Business segments
  • Nippon Shinyaku Co. Ltd. - Key offerings
  • Nippon Shinyaku Co. Ltd. - Segment focus
  • SWOT
15.14 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Segment focus
  • SWOT
15.15 Sandoz Group AG
  • Sandoz Group AG - Overview
  • Sandoz Group AG - Product / Service
  • Sandoz Group AG - Key offerings
  • SWOT
15.16 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
15.17 SK Chemicals Co. Ltd.
  • SK Chemicals Co. Ltd. - Overview
  • SK Chemicals Co. Ltd. - Product / Service
  • SK Chemicals Co. Ltd. - Key news
  • SK Chemicals Co. Ltd. - Key offerings
  • SWOT
15.18 Sun Pharmaceutical Industries
  • Sun Pharmaceutical Industries - Overview
  • Sun Pharmaceutical Industries - Product / Service
  • Sun Pharmaceutical Industries - Key news
  • Sun Pharmaceutical Industries - Key offerings
  • SWOT
16 Appendix
16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
16.4 Research methodology
  • Research methodology
16.5 Data procurement
  • Information sources
16.6 Data validation
  • Data validation
16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
16.8 Data synthesis
  • Data synthesis
16.9 360 degree market analysis
  • 360 degree market analysis
16.10 List of abbreviations
  • List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 6: Executive Summary - Chart on Market Segmentation by Product
Exhibit 7: Executive Summary - Chart on Market Segmentation by Type
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Erectile Dysfunction (ED) Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Distribution Channel Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Product Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - Type Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibit 39: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Distribution Channel
Exhibit 41: Data Table on Comparison by Distribution Channel
Exhibit 42: Chart on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hospital pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hospital pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Retail pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Retail pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Online pharmacy - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Online pharmacy - Year-over-year growth 2025-2030 (%)
Exhibit 54: Market opportunity by Distribution Channel ($ million)
Exhibit 55: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 56: Chart on Product - Market share 2025-2030 (%)
Exhibit 57: Data Table on Product - Market share 2025-2030 (%)
Exhibit 58: Chart on Comparison by Product
Exhibit 59: Data Table on Comparison by Product
Exhibit 60: Chart on Oral drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 61: Data Table on Oral drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 62: Chart on Oral drugs - Year-over-year growth 2025-2030 (%)
Exhibit 63: Data Table on Oral drugs - Year-over-year growth 2025-2030 (%)
Exhibit 64: Chart on Topical drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 65: Data Table on Topical drugs - Market size and forecast 2025-2030 ($ million)
Exhibit 66: Chart on Topical drugs - Year-over-year growth 2025-2030 (%)
Exhibit 67: Data Table on Topical drugs - Year-over-year growth 2025-2030 (%)
Exhibit 68: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 72: Market opportunity by Product ($ million)
Exhibit 73: Data Table on Market opportunity by Product ($ million)
Exhibit 74: Chart on Type - Market share 2025-2030 (%)
Exhibit 75: Data Table on Type - Market share 2025-2030 (%)
Exhibit 76: Chart on Comparison by Type
Exhibit 77: Data Table on Comparison by Type
Exhibit 78: Chart on Sildenafil - Market size and forecast 2025-2030 ($ million)
Exhibit 79: Data Table on Sildenafil - Market size and forecast 2025-2030 ($ million)
Exhibit 80: Chart on Sildenafil - Year-over-year growth 2025-2030 (%)
Exhibit 81: Data Table on Sildenafil - Year-over-year growth 2025-2030 (%)
Exhibit 82: Chart on Tadalafil - Market size and forecast 2025-2030 ($ million)
Exhibit 83: Data Table on Tadalafil - Market size and forecast 2025-2030 ($ million)
Exhibit 84: Chart on Tadalafil - Year-over-year growth 2025-2030 (%)
Exhibit 85: Data Table on Tadalafil - Year-over-year growth 2025-2030 (%)
Exhibit 86: Chart on Vardenafil - Market size and forecast 2025-2030 ($ million)
Exhibit 87: Data Table on Vardenafil - Market size and forecast 2025-2030 ($ million)
Exhibit 88: Chart on Vardenafil - Year-over-year growth 2025-2030 (%)
Exhibit 89: Data Table on Vardenafil - Year-over-year growth 2025-2030 (%)
Exhibit 90: Chart on Avanafil - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Avanafil - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Avanafil - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Avanafil - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 98: Market opportunity by Type ($ million)
Exhibit 99: Data Table on Market opportunity by Type ($ million)
Exhibit 100: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 101: Chart on Market share by geography 2025-2030 (%)
Exhibit 102: Data Table on Market share by geography 2025-2030 (%)
Exhibit 103: Chart on Geographic comparison
Exhibit 104: Data Table on Geographic comparison
Exhibit 105: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 106: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 107: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 108: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 109: Chart on Regional Comparison - North America
Exhibit 110: Data Table on Regional Comparison - North America
Exhibit 111: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 112: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 113: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 114: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 115: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 116: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 117: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 118: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 119: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Regional Comparison - Europe
Exhibit 128: Data Table on Regional Comparison - Europe
Exhibit 129: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 130: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 131: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 132: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 133: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 134: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 135: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 136: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 137: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Russia - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Russia - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Regional Comparison - Asia
Exhibit 162: Data Table on Regional Comparison - Asia
Exhibit 163: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 164: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 165: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 166: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 167: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Singapore - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Singapore - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Australia - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Australia - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 221: Market opportunity by geography ($ million)
Exhibit 222: Data Tables on Market opportunity by geography ($ million)
Exhibit 223: Impact of drivers and challenges in 2025 and 2030
Exhibit 224: Overview on criticality of inputs and factors of differentiation
Exhibit 225: Overview on factors of disruption
Exhibit 226: Impact of key risks on business
Exhibit 227: Companies covered
Exhibit 228: Company ranking index
Exhibit 229: Matrix on companies position and classification
Exhibit 230: A. Menarini Industrie Farma - Overview
Exhibit 231: A. Menarini Industrie Farma - Product / Service
Exhibit 232: A. Menarini Industrie Farma - Key offerings
Exhibit 233: SWOT
Exhibit 234: Aseric Pharma - Overview
Exhibit 235: Aseric Pharma - Product / Service
Exhibit 236: Aseric Pharma - Key offerings
Exhibit 237: SWOT
Exhibit 238: Aurobindo Pharma Ltd. - Overview
Exhibit 239: Aurobindo Pharma Ltd. - Product / Service
Exhibit 240: Aurobindo Pharma Ltd. - Key offerings
Exhibit 241: SWOT
Exhibit 242: Bayer AG - Overview
Exhibit 243: Bayer AG - Business segments
Exhibit 244: Bayer AG - Key news
Exhibit 245: Bayer AG - Key offerings
Exhibit 246: Bayer AG - Segment focus
Exhibit 247: SWOT
Exhibit 248: Cipla Inc. - Overview
Exhibit 249: Cipla Inc. - Business segments
Exhibit 250: Cipla Inc. - Key news
Exhibit 251: Cipla Inc. - Key offerings
Exhibit 252: Cipla Inc. - Segment focus
Exhibit 253: SWOT
Exhibit 254: Dong A Socio Holdings Co. Ltd. - Overview
Exhibit 255: Dong A Socio Holdings Co. Ltd. - Product / Service
Exhibit 256: Dong A Socio Holdings Co. Ltd. - Key offerings
Exhibit 257: SWOT
Exhibit 258: Dr. Reddys Laboratories Ltd. - Overview
Exhibit 259: Dr. Reddys Laboratories Ltd. - Business segments
Exhibit 260: Dr. Reddys Laboratories Ltd. - Key news
Exhibit 261: Dr. Reddys Laboratories Ltd. - Key offerings
Exhibit 262: Dr. Reddys Laboratories Ltd. - Segment focus
Exhibit 263: SWOT
Exhibit 264: Eli Lilly and Co. - Overview
Exhibit 265: Eli Lilly and Co. - Product / Service
Exhibit 266: Eli Lilly and Co. - Key offerings
Exhibit 267: SWOT
Exhibit 268: Lupin Ltd. - Overview
Exhibit 269: Lupin Ltd. - Business segments
Exhibit 270: Lupin Ltd. - Key news
Exhibit 271: Lupin Ltd. - Key offerings
Exhibit 272: Lupin Ltd. - Segment focus
Exhibit 273: SWOT
Exhibit 274: Nippon Shinyaku Co. Ltd. - Overview
Exhibit 275: Nippon Shinyaku Co. Ltd. - Business segments
Exhibit 276: Nippon Shinyaku Co. Ltd. - Key offerings
Exhibit 277: Nippon Shinyaku Co. Ltd. - Segment focus
Exhibit 278: SWOT
Exhibit 279: Pfizer Inc. - Overview
Exhibit 280: Pfizer Inc. - Business segments
Exhibit 281: Pfizer Inc. - Key news
Exhibit 282: Pfizer Inc. - Key offerings
Exhibit 283: Pfizer Inc. - Segment focus
Exhibit 284: SWOT
Exhibit 285: Sandoz Group AG - Overview
Exhibit 286: Sandoz Group AG - Product / Service
Exhibit 287: Sandoz Group AG - Key offerings
Exhibit 288: SWOT
Exhibit 289: Sanofi SA - Overview
Exhibit 290: Sanofi SA - Business segments
Exhibit 291: Sanofi SA - Key news
Exhibit 292: Sanofi SA - Key offerings
Exhibit 293: Sanofi SA - Segment focus
Exhibit 294: SWOT
Exhibit 295: SK Chemicals Co. Ltd. - Overview
Exhibit 296: SK Chemicals Co. Ltd. - Product / Service
Exhibit 297: SK Chemicals Co. Ltd. - Key news
Exhibit 298: SK Chemicals Co. Ltd. - Key offerings
Exhibit 299: SWOT
Exhibit 300: Sun Pharmaceutical Industries - Overview
Exhibit 301: Sun Pharmaceutical Industries - Product / Service
Exhibit 302: Sun Pharmaceutical Industries - Key news
Exhibit 303: Sun Pharmaceutical Industries - Key offerings
Exhibit 304: SWOT
Exhibit 305: Inclusions checklist
Exhibit 306: Exclusions checklist
Exhibit 307: Currency conversion rates for US$
Exhibit 308: Research methodology
Exhibit 309: Information sources
Exhibit 310: Data validation
Exhibit 311: Validation techniques employed for market sizing
Exhibit 312: Data synthesis
Exhibit 313: 360 degree market analysis
Exhibit 314: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global global erectile dysfunction (ed) drugs market: A. Menarini Industrie Farma, Aseric Pharma, Aurobindo Pharma Ltd., Bayer AG, Cipla Inc., Dong A Socio Holdings Co. Ltd., Dr. Reddys Laboratories Ltd., Eli Lilly and Co., Lupin Ltd., Nippon Shinyaku Co. Ltd., Pfizer Inc., Sandoz Group AG, Sanofi SA, SK Chemicals Co. Ltd., Sun Pharmaceutical Industries, Teva Pharmaceutical Ltd., Viatris Inc., VIVUS LLC.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is presence of novel drug formulations in late stages of development."

According to the report, one of the major drivers for this market is the rising demand for erectile dysfunction drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • A. Menarini Industrie Farma
  • Aseric Pharma
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • Cipla Inc.
  • Dong A Socio Holdings Co. Ltd.
  • Dr. Reddys Laboratories Ltd.
  • Eli Lilly and Co.
  • Lupin Ltd.
  • Nippon Shinyaku Co. Ltd.
  • Pfizer Inc.
  • Sandoz Group AG
  • Sanofi SA
  • SK Chemicals Co. Ltd.
  • Sun Pharmaceutical Industries
  • Teva Pharmaceutical Ltd.
  • Viatris Inc.
  • VIVUS LLC